Thank you to our Foundational and Sustaining members
Blue Cross and Blue Shield of Minnesota to drop insulin co-pay to $0 CVRx Receives FDA Approval for World’s First Heart Failure Neuromodulation Device Q&A: ‘The key is going to be providing information that’s actually helpful’ U.S. health care system must adopt nimbler, more transparent model Starkey Hearing Technologies Named Stevie Awards Winner New cancer […]
MINNEAPOLIS, August 20, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower® Control Kit for the ProteinSimpleTM- branded Maurice platform. This new kit enables users to collect, manage and report Maurice results with the industry leading Empower® 3 Software from WatersTM Corporation. Since its introduction in 2016, the Maurice platform […]
Fairview acquires Wisconsin-based Vibrant Health AtriCure offers $300m for SentreHeart Bio-Techne: $50m reagent plant support cell & genes Mayo Clinic invests in breast cancer imaging AI We’re Starting to Harness the Microbiome to Treat Disease Despite a Cold M&A Market in Minnesota, Deal Activity in Healthcare Remains Hot UK regulators OK Boston Scientific’s $4B BTG […]
MINNEAPOLIS and SOUTHPORT, August 13, 2019/PRNewswire/ — Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimpleTM-branded EllaTM immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the co-developed third generation CHO-HCP assay […]
MINNEAPOLIS, July 23, 2019 /PRNewswire/ — Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use […]
MINNEAPOLIS, July 17, 2019 /PRNewswire/ ‐‐ Bio‐Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8‐Plex cartridge format for the ProteinSimple™‐branded Ella™ automated immunoassay platform. This new cartridge format analyzes 32 samples for eight distinct analytes, bringing higher multiplex capabilities to the Ella platform. The 32×8 cartridge for Ella enables users to build […]
Boston Scientific plans for 75 new products by 2022 Top US hospital opens London clinic offering £5k ‘health MoTs’ Reprise Biomedical Raises $12.5 Million and Completes Spin-Off From Miromatrix Medical UnitedHealth Group Invests In Job Of The Future: ‘Data Scientists’ 6 MAA Members Make Forbes’ List of Best Employers for Women Joan Gabel takes helm […]
Expanding research tools for Spatial Genomics by combining molecular information with spatial context in one simple assay. MINNEAPOLIS, July 11, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics™-branded RNAscope platform with release of the RNAscope HiPlex Assay. The RNAscope platform is an advanced in situ hybridization assay that […]
MINNEAPOLIS, July 9, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that its President and CEO, Chuck Kummeth, was recently honored with the EY Entrepreneur Of The Year® 2019 Award in the Heartland. The EY awards program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance, and […]
Minneapolis, June 26, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the “Decade of Contribution Award” at the 2019 (10th) International Conference on Cell Therapy conference. This award recognized the commitment of Bio-Techne’s team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology industry. The 2019 (10th) […]